Lanean...

Vascular legacy: HOPE ADVANCEs to EMPA-REG and LEADER: A Surprising similarity

Recently reported cardiovascular outcome studies on empagliflozin (EMPA-REG) and liraglutide (LEADER) have spurred interest in this field of diabetology. This commentary compares and contrasts these studies with two equally important outcome trials conducted using blood pressure lowering agents. A c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Indian J Endocrinol Metab
Egile Nagusiak: Kalra, Sanjay, Sahay, Rakesh
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications & Media Pvt Ltd 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240071/
https://ncbi.nlm.nih.gov/pubmed/28217527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.194341
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!